Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine for Exercise Training in COPD and ILD
NCT03824834Phase 2Unknown
- Start
- Aug 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of morphine in chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD). Status: unknown.
02
Drugs
morphine
03
Conditions
chronic obstructive pulmonary disease (COPD)interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT03824834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03824834.